# ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

> **NCT06465017** · NA · TERMINATED · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 149 (actual)

## Conditions studied

- Tumor
- Solid Tumor
- Thyroid Cancer
- Positron-Emission Tomography

## Interventions

- **DIAGNOSTIC_TEST:** standard-of-care imaging (18F-FDG PET/CT), 68Ga-MY6349 PET/CT

## Key facts

- **NCT ID:** NCT06465017
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-01-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 149 (ACTUAL)
- **Why stopped:** The study was completed as planned after achieving the target enrollment and completing all protocol-specified procedures and follow-up.
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06465017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06465017, "ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06465017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*